. 2023 Jul 10;36:11308. doi: 10.3389/ti.2023.11308

TABLE 3.

Correlates of intentional non-adherence and bivariate analysis.

Variables	Values/scoring	Total sample	Intentional non-adherence
		N; mean ± SD N (%)	N; mean ± SD N (%)	OR ^a (95% CI)
		N = 1,397	N = 46	OR ^a (95% CI)
Predictors of the IMPB model
Intention to adhere to the immunosuppressants regimen	1 (strongly disagree) to 5 (strongly agree)	1,376; 4.69 ± 0.53	45; 4.41 ± 0.68	0.54* (0.38–0.77)**
Intention to adhere to the immunosuppressants regimen	Missing	21 (1.50)	1 (2.17)
Barriers to take immunosuppressants as prescribed	1 (never) to 5 (always)	1,378; 1.19 ± 0.30	45; 1.47 ± 0.54	4.90* (2.73–8.80)**
Barriers to take immunosuppressants as prescribed	Missing	19 (1.36)	1 (2.17)
Attitudes towards taking immunosuppressants (dimension positive attitudes/looking towards the future)	1 (strongly disagree) to 5 (strongly agree)	1,375; 4.46 ± 0.46	45; 4.46 ± 0.40	0.99 (0.51–1.89)
	Missing	22 (1.57)	1 (2.17)
Attitudes towards taking immunosuppressants (dimension worries)	1 (strongly disagree) to 5 (strongly agree)	1,370; 1.91 ± 0.57	45; 2.12 ± 0.60	*1.81 (1.15–2.85)**
	Missing	27 (1.93)	1 (2.17)
Perceived norms related to immunosuppressants	1 (strongly disagree) to 5 (strongly agree)	1,241; 1.30 ± 0.60	42; 1.43 ± 0.61	1.36 (0.89–2.08)
Perceived norms related to immunosuppressants	Missing	156 (11.17)	4 (8.70)
Self-efficacy with taking immunosuppressants	1 (not at all confident) to 5 (completely confident)	1,362; 4.36 ± 0.81	45; 3.95 ± 0.89	0.59* (0.44–0.80)**
Self-efficacy with taking immunosuppressants	Missing	35 (2.51)	1 (2.17)

OR, odds ratio; CI, confidence interval. *p < 0.05, **p < 0.01, ***p < 0.001.

^{^a}

Logistic regression for bivariate analysis [31], bold when significant.